English
简体中文
Total: £ 56.28
Published Date: 2026-01-20 | Pages: 134 | Tables: 129 | Medical Care
The global Spatial Transcriptomics Service market was valued at US$ 2506 million in 2025 and is anticipated to reach US$ 5226 million by 2032, at a CAGR of 11.2% from 2026 to 2032.
Spatial Transcriptomics is the ability to capture the positional context of transcriptional activity within intact tissue, either for regions or single cells. It defines an array of technologies enabling researchers to locate transcripts, often down to the subcellular level, providing an unbiased map of RNA molecules throughout tissue sections.These techniques often employ microscopy and next-generation sequencing to empower scientists to measure gene expression within a specific tissue or cellular context.
The North American market for Spatial Transcriptomics Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Spatial Transcriptomics Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Spatial Transcriptomics Service in Pathology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Spatial Transcriptomics Service include CD Genomics, Single Cell Discoveries BV, AcelaBio, SciLifeLab, SeqMatic LLC, Firalis Molecular Precision, Indivumed Services, Creative Biolabs, Macrogen Europe, Molecular Genomics Pte Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Spatial Transcriptomics Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Spatial Transcriptomics Service. The Spatial Transcriptomics Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Spatial Transcriptomics Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Spatial Transcriptomics Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CD Genomics
Single Cell Discoveries BV
AcelaBio
SciLifeLab
SeqMatic LLC
Firalis Molecular Precision
Indivumed Services
Creative Biolabs
Macrogen Europe
Molecular Genomics Pte Ltd.
OBiO Technology ( Shanghai ) Corp.,Ltd.
BGI Genomics
Dynamic-biosystems
TianGen
Novogene
Beijing Sun-Novo Pharmaceutical Research (Novopathway)
Shanghai Novelbio Medical Tech
Singleron Biotechnologies
SHANGHAI OE Biotech
Gene Denovo
Segment by Type
10x Genomics Visium Based
Nanostring Based
Vizgen MERSCOPE Based
Other
Segment by Application
Pathology
Immunology
Developmental Biology
Oncology
Neuroscience
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Spatial Transcriptomics Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Transcriptomics Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 10x Genomics Visium Based
1.2.3 Nanostring Based
1.2.4 Vizgen MERSCOPE Based
1.2.5 Other
1.3 Market by Application
1.3.1 Global Spatial Transcriptomics Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pathology
1.3.3 Immunology
1.3.4 Developmental Biology
1.3.5 Oncology
1.3.6 Neuroscience
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Transcriptomics Service Market Perspective (2021–2032)
2.2 Global Spatial Transcriptomics Service Growth Trends by Region
2.2.1 Global Spatial Transcriptomics Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Spatial Transcriptomics Service Historic Market Size by Region (2021–2026)
2.2.3 Spatial Transcriptomics Service Forecasted Market Size by Region (2027–2032)
2.3 Spatial Transcriptomics Service Market Dynamics
2.3.1 Spatial Transcriptomics Service Industry Trends
2.3.2 Spatial Transcriptomics Service Market Drivers
2.3.3 Spatial Transcriptomics Service Market Challenges
2.3.4 Spatial Transcriptomics Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Transcriptomics Service Players by Revenue
3.1.1 Global Top Spatial Transcriptomics Service Players by Revenue (2021–2026)
3.1.2 Global Spatial Transcriptomics Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Spatial Transcriptomics Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Spatial Transcriptomics Service Revenue
3.4 Global Spatial Transcriptomics Service Market Concentration Ratio
3.4.1 Global Spatial Transcriptomics Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Transcriptomics Service Revenue in 2025
3.5 Global Key Players of Spatial Transcriptomics Service Head Offices and Areas Served
3.6 Global Key Players of Spatial Transcriptomics Service, Products and Applications
3.7 Global Key Players of Spatial Transcriptomics Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Spatial Transcriptomics Service Breakdown Data by Type
4.1 Global Spatial Transcriptomics Service Historic Market Size by Type (2021–2026)
4.2 Global Spatial Transcriptomics Service Forecasted Market Size by Type (2027–2032)
5 Spatial Transcriptomics Service Breakdown Data by Application
5.1 Global Spatial Transcriptomics Service Historic Market Size by Application (2021–2026)
5.2 Global Spatial Transcriptomics Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Spatial Transcriptomics Service Market Size (2021–2032)
6.2 North America Spatial Transcriptomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Spatial Transcriptomics Service Market Size by Country (2021–2026)
6.4 North America Spatial Transcriptomics Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Transcriptomics Service Market Size (2021–2032)
7.2 Europe Spatial Transcriptomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Spatial Transcriptomics Service Market Size by Country (2021–2026)
7.4 Europe Spatial Transcriptomics Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Spatial Transcriptomics Service Market Size (2021–2032)
8.2 Asia-Pacific Spatial Transcriptomics Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Spatial Transcriptomics Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Spatial Transcriptomics Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Spatial Transcriptomics Service Market Size (2021–2032)
9.2 Latin America Spatial Transcriptomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Spatial Transcriptomics Service Market Size by Country (2021–2026)
9.4 Latin America Spatial Transcriptomics Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Transcriptomics Service Market Size (2021–2032)
10.2 Middle East & Africa Spatial Transcriptomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Spatial Transcriptomics Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Spatial Transcriptomics Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Details
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Spatial Transcriptomics Service Introduction
11.1.4 CD Genomics Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.1.5 CD Genomics Recent Development
11.2 Single Cell Discoveries BV
11.2.1 Single Cell Discoveries BV Company Details
11.2.2 Single Cell Discoveries BV Business Overview
11.2.3 Single Cell Discoveries BV Spatial Transcriptomics Service Introduction
11.2.4 Single Cell Discoveries BV Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.2.5 Single Cell Discoveries BV Recent Development
11.3 AcelaBio
11.3.1 AcelaBio Company Details
11.3.2 AcelaBio Business Overview
11.3.3 AcelaBio Spatial Transcriptomics Service Introduction
11.3.4 AcelaBio Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.3.5 AcelaBio Recent Development
11.4 SciLifeLab
11.4.1 SciLifeLab Company Details
11.4.2 SciLifeLab Business Overview
11.4.3 SciLifeLab Spatial Transcriptomics Service Introduction
11.4.4 SciLifeLab Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.4.5 SciLifeLab Recent Development
11.5 SeqMatic LLC
11.5.1 SeqMatic LLC Company Details
11.5.2 SeqMatic LLC Business Overview
11.5.3 SeqMatic LLC Spatial Transcriptomics Service Introduction
11.5.4 SeqMatic LLC Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.5.5 SeqMatic LLC Recent Development
11.6 Firalis Molecular Precision
11.6.1 Firalis Molecular Precision Company Details
11.6.2 Firalis Molecular Precision Business Overview
11.6.3 Firalis Molecular Precision Spatial Transcriptomics Service Introduction
11.6.4 Firalis Molecular Precision Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.6.5 Firalis Molecular Precision Recent Development
11.7 Indivumed Services
11.7.1 Indivumed Services Company Details
11.7.2 Indivumed Services Business Overview
11.7.3 Indivumed Services Spatial Transcriptomics Service Introduction
11.7.4 Indivumed Services Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.7.5 Indivumed Services Recent Development
11.8 Creative Biolabs
11.8.1 Creative Biolabs Company Details
11.8.2 Creative Biolabs Business Overview
11.8.3 Creative Biolabs Spatial Transcriptomics Service Introduction
11.8.4 Creative Biolabs Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.8.5 Creative Biolabs Recent Development
11.9 Macrogen Europe
11.9.1 Macrogen Europe Company Details
11.9.2 Macrogen Europe Business Overview
11.9.3 Macrogen Europe Spatial Transcriptomics Service Introduction
11.9.4 Macrogen Europe Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.9.5 Macrogen Europe Recent Development
11.10 Molecular Genomics Pte Ltd.
11.10.1 Molecular Genomics Pte Ltd. Company Details
11.10.2 Molecular Genomics Pte Ltd. Business Overview
11.10.3 Molecular Genomics Pte Ltd. Spatial Transcriptomics Service Introduction
11.10.4 Molecular Genomics Pte Ltd. Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.10.5 Molecular Genomics Pte Ltd. Recent Development
11.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Spatial Transcriptomics Service Introduction
11.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.12 BGI Genomics
11.12.1 BGI Genomics Company Details
11.12.2 BGI Genomics Business Overview
11.12.3 BGI Genomics Spatial Transcriptomics Service Introduction
11.12.4 BGI Genomics Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.12.5 BGI Genomics Recent Development
11.13 Dynamic-biosystems
11.13.1 Dynamic-biosystems Company Details
11.13.2 Dynamic-biosystems Business Overview
11.13.3 Dynamic-biosystems Spatial Transcriptomics Service Introduction
11.13.4 Dynamic-biosystems Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.13.5 Dynamic-biosystems Recent Development
11.14 TianGen
11.14.1 TianGen Company Details
11.14.2 TianGen Business Overview
11.14.3 TianGen Spatial Transcriptomics Service Introduction
11.14.4 TianGen Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.14.5 TianGen Recent Development
11.15 Novogene
11.15.1 Novogene Company Details
11.15.2 Novogene Business Overview
11.15.3 Novogene Spatial Transcriptomics Service Introduction
11.15.4 Novogene Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.15.5 Novogene Recent Development
11.16 Beijing Sun-Novo Pharmaceutical Research (Novopathway)
11.16.1 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Company Details
11.16.2 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Business Overview
11.16.3 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Spatial Transcriptomics Service Introduction
11.16.4 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.16.5 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Recent Development
11.17 Shanghai Novelbio Medical Tech
11.17.1 Shanghai Novelbio Medical Tech Company Details
11.17.2 Shanghai Novelbio Medical Tech Business Overview
11.17.3 Shanghai Novelbio Medical Tech Spatial Transcriptomics Service Introduction
11.17.4 Shanghai Novelbio Medical Tech Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.17.5 Shanghai Novelbio Medical Tech Recent Development
11.18 Singleron Biotechnologies
11.18.1 Singleron Biotechnologies Company Details
11.18.2 Singleron Biotechnologies Business Overview
11.18.3 Singleron Biotechnologies Spatial Transcriptomics Service Introduction
11.18.4 Singleron Biotechnologies Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.18.5 Singleron Biotechnologies Recent Development
11.19 SHANGHAI OE Biotech
11.19.1 SHANGHAI OE Biotech Company Details
11.19.2 SHANGHAI OE Biotech Business Overview
11.19.3 SHANGHAI OE Biotech Spatial Transcriptomics Service Introduction
11.19.4 SHANGHAI OE Biotech Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.19.5 SHANGHAI OE Biotech Recent Development
11.20 Gene Denovo
11.20.1 Gene Denovo Company Details
11.20.2 Gene Denovo Business Overview
11.20.3 Gene Denovo Spatial Transcriptomics Service Introduction
11.20.4 Gene Denovo Revenue in Spatial Transcriptomics Service Business (2021–2026)
11.20.5 Gene Denovo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Spatial Transcriptomics Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 10x Genomics Visium Based
Table 3. Key Players of Nanostring Based
Table 4. Key Players of Vizgen MERSCOPE Based
Table 5. Key Players of Other
Table 6. Global Spatial Transcriptomics Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Spatial Transcriptomics Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Spatial Transcriptomics Service Market Size by Region (US$ Million), 2021–2026
Table 9. Global Spatial Transcriptomics Service Market Share by Region (2021–2026)
Table 10. Global Spatial Transcriptomics Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Spatial Transcriptomics Service Market Share by Region (2027–2032)
Table 12. Spatial Transcriptomics Service Market Trends
Table 13. Spatial Transcriptomics Service Market Drivers
Table 14. Spatial Transcriptomics Service Market Challenges
Table 15. Spatial Transcriptomics Service Market Restraints
Table 16. Global Spatial Transcriptomics Service Revenue by Players (US$ Million), 2021–2026
Table 17. Global Spatial Transcriptomics Service Market Share by Players (2021–2026)
Table 18. Global Top Spatial Transcriptomics Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Spatial Transcriptomics Service Revenue, 2025
Table 19. Ranking of Global Top Spatial Transcriptomics Service Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Spatial Transcriptomics Service Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Spatial Transcriptomics Service, Headquarters and Area Served
Table 22. Global Key Players of Spatial Transcriptomics Service, Products and Applications
Table 23. Global Key Players of Spatial Transcriptomics Service, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Spatial Transcriptomics Service Market Size by Type (US$ Million), 2021–2026
Table 26. Global Spatial Transcriptomics Service Revenue Market Share by Type (2021–2026)
Table 27. Global Spatial Transcriptomics Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Spatial Transcriptomics Service Revenue Market Share by Type (2027–2032)
Table 29. Global Spatial Transcriptomics Service Market Size by Application (US$ Million), 2021–2026
Table 30. Global Spatial Transcriptomics Service Revenue Market Share by Application (2021–2026)
Table 31. Global Spatial Transcriptomics Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Spatial Transcriptomics Service Revenue Market Share by Application (2027–2032)
Table 33. North America Spatial Transcriptomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Spatial Transcriptomics Service Market Size by Country (US$ Million), 2021–2026
Table 35. North America Spatial Transcriptomics Service Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Spatial Transcriptomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Spatial Transcriptomics Service Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Spatial Transcriptomics Service Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Spatial Transcriptomics Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Spatial Transcriptomics Service Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Spatial Transcriptomics Service Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Spatial Transcriptomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Spatial Transcriptomics Service Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Spatial Transcriptomics Service Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Spatial Transcriptomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Spatial Transcriptomics Service Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Spatial Transcriptomics Service Market Size by Country (US$ Million), 2027–2032
Table 48. CD Genomics Company Details
Table 49. CD Genomics Business Overview
Table 50. CD Genomics Spatial Transcriptomics Service Product
Table 51. CD Genomics Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 52. CD Genomics Recent Development
Table 53. Single Cell Discoveries BV Company Details
Table 54. Single Cell Discoveries BV Business Overview
Table 55. Single Cell Discoveries BV Spatial Transcriptomics Service Product
Table 56. Single Cell Discoveries BV Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 57. Single Cell Discoveries BV Recent Development
Table 58. AcelaBio Company Details
Table 59. AcelaBio Business Overview
Table 60. AcelaBio Spatial Transcriptomics Service Product
Table 61. AcelaBio Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 62. AcelaBio Recent Development
Table 63. SciLifeLab Company Details
Table 64. SciLifeLab Business Overview
Table 65. SciLifeLab Spatial Transcriptomics Service Product
Table 66. SciLifeLab Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 67. SciLifeLab Recent Development
Table 68. SeqMatic LLC Company Details
Table 69. SeqMatic LLC Business Overview
Table 70. SeqMatic LLC Spatial Transcriptomics Service Product
Table 71. SeqMatic LLC Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 72. SeqMatic LLC Recent Development
Table 73. Firalis Molecular Precision Company Details
Table 74. Firalis Molecular Precision Business Overview
Table 75. Firalis Molecular Precision Spatial Transcriptomics Service Product
Table 76. Firalis Molecular Precision Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 77. Firalis Molecular Precision Recent Development
Table 78. Indivumed Services Company Details
Table 79. Indivumed Services Business Overview
Table 80. Indivumed Services Spatial Transcriptomics Service Product
Table 81. Indivumed Services Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 82. Indivumed Services Recent Development
Table 83. Creative Biolabs Company Details
Table 84. Creative Biolabs Business Overview
Table 85. Creative Biolabs Spatial Transcriptomics Service Product
Table 86. Creative Biolabs Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 87. Creative Biolabs Recent Development
Table 88. Macrogen Europe Company Details
Table 89. Macrogen Europe Business Overview
Table 90. Macrogen Europe Spatial Transcriptomics Service Product
Table 91. Macrogen Europe Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 92. Macrogen Europe Recent Development
Table 93. Molecular Genomics Pte Ltd. Company Details
Table 94. Molecular Genomics Pte Ltd. Business Overview
Table 95. Molecular Genomics Pte Ltd. Spatial Transcriptomics Service Product
Table 96. Molecular Genomics Pte Ltd. Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 97. Molecular Genomics Pte Ltd. Recent Development
Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Spatial Transcriptomics Service Product
Table 101. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 102. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
Table 103. BGI Genomics Company Details
Table 104. BGI Genomics Business Overview
Table 105. BGI Genomics Spatial Transcriptomics Service Product
Table 106. BGI Genomics Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 107. BGI Genomics Recent Development
Table 108. Dynamic-biosystems Company Details
Table 109. Dynamic-biosystems Business Overview
Table 110. Dynamic-biosystems Spatial Transcriptomics Service Product
Table 111. Dynamic-biosystems Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 112. Dynamic-biosystems Recent Development
Table 113. TianGen Company Details
Table 114. TianGen Business Overview
Table 115. TianGen Spatial Transcriptomics Service Product
Table 116. TianGen Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 117. TianGen Recent Development
Table 118. Novogene Company Details
Table 119. Novogene Business Overview
Table 120. Novogene Spatial Transcriptomics Service Product
Table 121. Novogene Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 122. Novogene Recent Development
Table 123. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Company Details
Table 124. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Business Overview
Table 125. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Spatial Transcriptomics Service Product
Table 126. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 127. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Recent Development
Table 128. Shanghai Novelbio Medical Tech Company Details
Table 129. Shanghai Novelbio Medical Tech Business Overview
Table 130. Shanghai Novelbio Medical Tech Spatial Transcriptomics Service Product
Table 131. Shanghai Novelbio Medical Tech Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 132. Shanghai Novelbio Medical Tech Recent Development
Table 133. Singleron Biotechnologies Company Details
Table 134. Singleron Biotechnologies Business Overview
Table 135. Singleron Biotechnologies Spatial Transcriptomics Service Product
Table 136. Singleron Biotechnologies Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 137. Singleron Biotechnologies Recent Development
Table 138. SHANGHAI OE Biotech Company Details
Table 139. SHANGHAI OE Biotech Business Overview
Table 140. SHANGHAI OE Biotech Spatial Transcriptomics Service Product
Table 141. SHANGHAI OE Biotech Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 142. SHANGHAI OE Biotech Recent Development
Table 143. Gene Denovo Company Details
Table 144. Gene Denovo Business Overview
Table 145. Gene Denovo Spatial Transcriptomics Service Product
Table 146. Gene Denovo Revenue in Spatial Transcriptomics Service Business (US$ Million), 2021–2026
Table 147. Gene Denovo Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Spatial Transcriptomics Service Picture
Figure 2. Global Spatial Transcriptomics Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Spatial Transcriptomics Service Market Share by Type: 2025 vs 2032
Figure 4. 10x Genomics Visium Based Features
Figure 5. Nanostring Based Features
Figure 6. Vizgen MERSCOPE Based Features
Figure 7. Other Features
Figure 8. Global Spatial Transcriptomics Service Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Spatial Transcriptomics Service Market Share by Application: 2025 vs 2032
Figure 10. Pathology Case Studies
Figure 11. Immunology Case Studies
Figure 12. Developmental Biology Case Studies
Figure 13. Oncology Case Studies
Figure 14. Neuroscience Case Studies
Figure 15. Other Case Studies
Figure 16. Spatial Transcriptomics Service Report Years Considered
Figure 17. Global Spatial Transcriptomics Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Spatial Transcriptomics Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Spatial Transcriptomics Service Market Share by Region: 2025 vs 2032
Figure 20. Global Spatial Transcriptomics Service Market Share by Players in 2025
Figure 21. Global Spatial Transcriptomics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Spatial Transcriptomics Service Revenue in 2025
Figure 23. North America Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Spatial Transcriptomics Service Market Share by Country (2021–2032)
Figure 25. United States Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Spatial Transcriptomics Service Market Share by Country (2021–2032)
Figure 29. Germany Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Spatial Transcriptomics Service Market Share by Region (2021–2032)
Figure 37. China Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Spatial Transcriptomics Service Market Share by Country (2021–2032)
Figure 45. Mexico Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Spatial Transcriptomics Service Market Share by Country (2021–2032)
Figure 49. Israel Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Spatial Transcriptomics Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. CD Genomics Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 53. Single Cell Discoveries BV Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 54. AcelaBio Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 55. SciLifeLab Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 56. SeqMatic LLC Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 57. Firalis Molecular Precision Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 58. Indivumed Services Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 59. Creative Biolabs Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 60. Macrogen Europe Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 61. Molecular Genomics Pte Ltd. Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 62. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 63. BGI Genomics Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 64. Dynamic-biosystems Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 65. TianGen Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 66. Novogene Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 67. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 68. Shanghai Novelbio Medical Tech Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 69. Singleron Biotechnologies Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 70. SHANGHAI OE Biotech Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 71. Gene Denovo Revenue Growth Rate in Spatial Transcriptomics Service Business (2021–2026)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
